Fatma Shahout did her B.Sc. in pharmaceutical science at the faculty of Medical Technology in Libya, and her M.Sc. in Pharmacology, at Nottingham Trent University (NTU), UK. She obtained her PhD in Biology and keep going now as a PostDoc in our team. Her research is focused on compound self-aggregation + their properties and fragment phenotypic screening (FBLD) to target breast cancer. Fatma always wanted to pursue her studies in an international environment and to increase her understanding through a community and educational exchange. She is fascinated by the field of cancer mechanisms and treatments.